Form 483

Eli Lilly and Company Form 483, 2024-11-26

FDA issued a Form 483 to Eli Lilly and Company on 2024-11-26 with 1 public-safe observation.

483· Form 483 issuedMedical Devices & Rad Health1 observation

Eli Lilly and Company · Concord, United States · Issued November 26, 2024

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Nov 2024
21 CFR 211.63

Equipment Design, Size and Location

Cited by Jocelyn C Turner, Sonya M Edmonds

Inspected site

ELEli Lilly and CompanyConcord, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.63Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 1 observation

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere